Fresenius Buys Full Ownership of Biosimilars Platform
Fresenius is acquiring full ownership of its biosimilars platform through an acquisition.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.